![Jolanta Airey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Jolanta Airey is currently Chief Medical Officer at Acrux Ltd. since 2026.
Formerly, served as Chief Medical Officer at Cynata Therapeutics Ltd. from 2021 to 2026, Director-Translational Development at CSL Ltd. from 2017 to 2021, and held the position of Head-Clinical Development Physician at CSL Seqirus Inc. Education includes a doctorate from Vilnius University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACRUX LIMITED | Director Técnico/Científico/I+D | 24/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Director Técnico/Científico/I+D | 01/01/2026 |
| CSL LIMITED | Corporate Officer/Principal | 01/10/2021 |
Csl Seqirus
 Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
 Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
 Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
